Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer

SIMPLE SUMMARY: Lung cancer remains one of the most common and difficult cancers to treat. However, excellent progress in identifying the genetic causes of lung cancers has revealed many of the mutant proteins driving progression of this cancer. This in turn has led to development of new precision m...

Descripción completa

Detalles Bibliográficos
Autores principales: Papageorgiou, Savvas, Pashley, Sarah L., O’Regan, Laura, Khan, Sam, Bayliss, Richard, Fry, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325236/
https://www.ncbi.nlm.nih.gov/pubmed/35884511
http://dx.doi.org/10.3390/cancers14143452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325236/
https://www.ncbi.nlm.nih.gov/pubmed/35884511
http://dx.doi.org/10.3390/cancers14143452

Ejemplares similares